|
Quotes & Info
|
| KIPS > SEC Filings for KIPS > Form 8-K on 22-Aug-2012 | All Recent SEC Filings |
22-Aug-2012
Other Events, Financial Statements and Exhibits
On August 22, 2012, Kips Bay Medical, Inc. (the "Company") issued a press
release announcing that the Company has commenced its feasibility trial (eMESH
I) in Bern, Switzerland and that the U.S. Food and Drug Administration has
requested additional information on the pre-clinical design testing of the
Company's eSVS Mesh. The full text of the press release is set forth in
Exhibit 99.1 attached hereto and is incorporated by reference in this Current
Report on Form 8-K as if fully set forth herein.
(a) Financial statements: None
(b) Pro forma financial information: None
(c) Shell company transactions: None
(d) Exhibits: 99.1 - Press Release dated August 22, 2012
|
|